Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - A clinical research center study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2198-2203

  Lovejoy, Jennifer C ^a,b   Bray, George A ^a   Bourgeois, Michael O ^b   Macchiavelli, Raul ^a,b   Rood, Jennifer C ^a   Greeson, Charles ^c   Partington, Curtis ^c  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Digital Diagnostics Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NANDROLONE DECANOATE; SPIRONOLACTONE;

ACNE; ADULT; ANDROGEN METABOLISM; ARTICLE; BASAL METABOLIC RATE; BODY DISTRIBUTION; BODY FAT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HAIR COLOR; HEADACHE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; ANDROGEN ANTAGONISTS; ANDROGENS; BODY COMPOSITION; CARDIOVASCULAR DISEASES; FEMALE; HORMONES; HUMANS; NANDROLONE; OBESITY; POSTMENOPAUSE; RISK FACTORS; SPIRONOLACTONE;

EID: 0030010984     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2198     Document Type: Article

References (26)

1. Despres J-P, Nadeau A, Tremblay A, et al. 1989 Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes. 38:304-309.
2. Lapidus L, Bengtsson C, Bjorntorp P. 1994 The quantitative relationship between "the metabolic syndrome" and abdominal obesity in women. Obesity Res. 2:372-377.
3. Haffner SM, Mitchell BD, Hazuda HP, Stern MP. 1991 Greater influence of central distribution of adipose tissue on incidence of non-insulin-dependent diabetes in women than men. Am J Clin Nutr. 53:1312-1317.
4. Johnson D, Prud'homme D, Despres J-P, Nadeau A, Tremblay A, Bouchard C. 1992 Relationship of abdominal obesity to hyperinsulinemia and high blood pressure in men. Int J Obesity. 16:881-890.
5. Seidell JC, Andres R, Sorkin JD, Muller DC. 1994 The sagittal waist diameter and mortality in men: the Baltimore Longitudinal Study on Aging. Int J Obesity. 18:61-67.
6. Kumagai S, Tanaka H, Kitajima H, Kono S, et al. 1993 Relationships of lipid and glucose metabolism with waist-to-hip ratio and physical fitness in obese men. Int J Obesity. 17:437-440.
7. Bjorntorp P. 1993 Visceral obesity: a "civilization syndrome." Obesity Res. 1:206-222.
8. Borkan GA, Hults DE, Gerzof SG, Robbins AH, Silbert CK. 1983 Age changes in body composition revealed by computed tomography. J Gerontol. 38:673-677.
9. Laws A, Terry RB, Barrett-Connor E. 1990 Behavioral covariates of waist-to-hip ratio in Rancho Bernardo. Am J Public Health. 80:1358-1362.
10. Marin P, Darin N, Amemeiya T, Andersson B, Jern S., Bjorntorp P. 1992 Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 41:882-886.
11. Kissebah AH, Peiris AN. 1989 Biology of regional fat distribution: relationship to non-insulin dependent diabetes mellitus. Diabetes Metab Rev. 5:83-109.
12. Yen SS. 1980 The polycystic ovarian syndrome. Clin Endocrinol (Oxf). 12: 177-207.
13. Marin P, Holmang S, Jonsson L, Sjostrom L, et al. 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obesity. 16:991-997.
14. Marin P, Holmang S, Gustafsson C, et al. 1993 Androgen treatment of abdominally obese men. Obesity Res. 1:245-251.
15. Lovejoy JC, Bray GA, Greeson CS, et al. 1995 Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases visceral, abdominal fat in obese, older men. Int J Obesity. 19:614-624.
16. Welch S, Gebhart SSP, Bergman RN, Phillips LS. 1990 Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab. 71:1508-1518.
17. Bergman RN, Ider YZ, Bowden CR, Cobelli C. 1979 Quantitative estimation of insulin sensitivity. Am J Physiol. 236:E667-E677.
18. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. 1991 Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 40:1323-1326.
19. Mooradian AD, Morley JE, Korenman SG. 1987 Biological actions of androgens. Endocr Rev. 8:1-28.
20. Bray GA, Raben MS, Londono J, Gallagher Jr TF. 1971 Effects of triiodothyronine, growth hormone, and anabolic steroids on nitrogen excretion and oxygen consumption in obese patients. J Clin Endocrinol Metab. 33:293-300.
21. Racette SB, Schoeller DA, Kushner RF, Neil KM, Herling-Iaffaldano K. 1995 Effects of aerobic exercise and dietary carbohydrate on energy expenditure and body composition during weight reduction in obese women. Am J Clin Nutr. 61:486-494.
22. Pavlou KN, Steffee WP, Lerman RH. 1985 Effects of dieting and exercise on lean body mass, oxygen uptake, and strength. Med Sci Sports Exer. 17:466-471.
23. Glazer, G. 1991 Atherogenic effects of anabolic steroids on serum lipid levels. Arch Intern Med. 151:1925-1933.
24. Correa R, Arteaga E, Lopez X, et al. 1990 The effect of a peripheral androgenic androgenic blockade on plasma lipoproteins in hirsutism patients. Revista Med. Chile. 118:1362-1366.
25. Aloia JF, Field RA. 1976 The effect of androgens and related substances on carbohydrate metabolism, lipid metabolism and diabetes mellitus. Pharmacol Ther C. 1:241-257.
26. Dunaif A, Green G, Futterweit W, Dobrjansky A. 1990 Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 70:699-704.